Linopirdine
Systematic (IUPAC) name | |
---|---|
1-phenyl-3,3-bis(pyridin-4-ylmethyl)-1,3-dihydro-2H-indol-2-one | |
Clinical data | |
Legal status | ? |
Identifiers | |
CAS number | 105431-72-9 |
ATC code | N06BX09 |
PubChem | CID 3932 |
IUPHAR ligand | 2599 |
ChemSpider | 3795 |
UNII | I5TB3NZ94T |
KEGG | D04741 |
ChEMBL | CHEMBL319111 |
Chemical data | |
Formula | C26H21N3O |
Mol. mass | 391.465 g/mol |
SMILES
| |
| |
(what is this?) (verify) | |
Linopirdine is a putative cognition-enhancing drug with a novel mechanism of action. Linopirdine blocks the KCNQ2\3 heteromer M current with an IC50 of 2.4nM[1] disinhibiting acetylcholine release, and increasing hippocampal CA3-schaffer collateral mediated glutamate release onto CA1 pyramidal neurons.[2] In a murine model linopirdine is able to nearly completely reverse the senescence-related decline in cortical c-FOS, an effect which is blocked by atropine and MK-801, suggesting Linopirdine can compensate for the age related decline in acetylcholine release.[3] Linopirdine also blocks homomeric KCNQ1 and KCNQ4 voltage gated potassium channels which contribute to vascular tone with substantially less selectivity than KCNQ2/3.[1]
See also
References
- ↑ 1.0 1.1 Schnee, M. E.; Brown, B. S. (1998). "Selectivity of linopirdine (DuP 996), a neurotransmitter release enhancer, in blocking voltage-dependent and calcium-activated potassium currents in hippocampal neurons". The Journal of pharmacology and experimental therapeutics 286 (2): 709–717. PMID 9694925.
- ↑ Sun, J.; Kapur, J. (2012). "M-type potassium channels modulate Schaffer collateral-CA1 glutamatergic synaptic transmission". The Journal of Physiology 590 (16): 3953–3964. doi:10.1113/jphysiol.2012.235820. PMC 3476642. PMID 22674722.
- ↑ Dent, G. W.; Rule, B. L.; Zhan, Y.; Grzanna, R. (2001). "The acetylcholine release enhancer linopirdine induces Fos in neocortex of aged rats". Neurobiology of aging 22 (3): 485–494. PMID 11378256.
|